Int J Med Sci 2020; 17(1):97-102. doi:10.7150/ijms.37675 This issue Cite

Research Paper

Angiopoietin-2 gene polymorphisms are biomarkers for the development and progression of colorectal cancer in Han Chinese

Zhang Du1*, Chih-Hsin Tang2,3,4*, Li-Jun Li1, Le Kang5, Jin Zhao5, Lulu Jin5, Chao-Qun Wang6✉, Chen-Ming Su7✉

1. Department of Anorectal Surgery, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, China.
2. School of Medicine, China Medical University, Taichung, Taiwan.
3. Chinese Medicine Research Center, China Medical University, Taichung, Taiwan.
4. Department of Biotechnology, College of Health Science, Asia University, Taichung, Taiwan.
5. Department of Biomedical Sciences Laboratory, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, China.
6. Department of Pathology, Affiliated Dongyang Hospital of Wenzhou Medical University, Dongyang, Zhejiang, China.
7. Department of Sports Medicine, China Medical University, Taichung, Taiwan.
*These authors have contributed equally to this work.

Citation:
Du Z, Tang CH, Li LJ, Kang L, Zhao J, Jin L, Wang CQ, Su CM. Angiopoietin-2 gene polymorphisms are biomarkers for the development and progression of colorectal cancer in Han Chinese. Int J Med Sci 2020; 17(1):97-102. doi:10.7150/ijms.37675. https://www.medsci.org/v17p0097.htm
Other styles

File import instruction

Abstract

Colorectal cancer (CRC) is one of the most common cancers in Han Chinese and is characterized by low rates of early diagnosis and poor survival rates. Angiopoietin-2 (Ang2), an endothelial tyrosine kinase, is involved in CRC progression, but little is known about the association between single nucleotide polymorphisms (SNPs) and diagnosis or prognosis of CRC. This study reports on the association between 5 SNPs of the Angpt2 gene (rs2442598, rs734701, rs1823375, 11137037, and rs12674822) and CRC susceptibility as well as clinical outcomes in 379 patients with CRC and in 1,043 cancer-free healthy controls. Carriers of the CG allele at rs1823375 and those with the GT+TT allele of the variant rs12674822 were at greater risk of CRC than their respective wild-type counterparts. Moreover, carriers of the GT or GT+TT allele in rs12674822 were significantly more likely to have tumor involvement in both the colon and rectum compared with wild-type (GG) carriers, while 5-year progression-free survival was also significantly worse in those carrying the GT+TT allele in rs12674822 compared with wild-type carriers. Our study is the first to describe correlations between Angpt2 polymorphisms and CRC development and progression in people of Chinese Han ethnicity.

Keywords: Angiopoietin-2, colorectal cancer, polymorphism


Citation styles

APA
Du, Z., Tang, C.H., Li, L.J., Kang, L., Zhao, J., Jin, L., Wang, C.Q., Su, C.M. (2020). Angiopoietin-2 gene polymorphisms are biomarkers for the development and progression of colorectal cancer in Han Chinese. International Journal of Medical Sciences, 17(1), 97-102. https://doi.org/10.7150/ijms.37675.

ACS
Du, Z.; Tang, C.H.; Li, L.J.; Kang, L.; Zhao, J.; Jin, L.; Wang, C.Q.; Su, C.M. Angiopoietin-2 gene polymorphisms are biomarkers for the development and progression of colorectal cancer in Han Chinese. Int. J. Med. Sci. 2020, 17 (1), 97-102. DOI: 10.7150/ijms.37675.

NLM
Du Z, Tang CH, Li LJ, Kang L, Zhao J, Jin L, Wang CQ, Su CM. Angiopoietin-2 gene polymorphisms are biomarkers for the development and progression of colorectal cancer in Han Chinese. Int J Med Sci 2020; 17(1):97-102. doi:10.7150/ijms.37675. https://www.medsci.org/v17p0097.htm

CSE
Du Z, Tang CH, Li LJ, Kang L, Zhao J, Jin L, Wang CQ, Su CM. 2020. Angiopoietin-2 gene polymorphisms are biomarkers for the development and progression of colorectal cancer in Han Chinese. Int J Med Sci. 17(1):97-102.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image